Former Scientific Officer at Tsan Yuk Hospital, HK;
Genetics and Biochemistry Scientist;
Prenatal Diagnosis & Cytogenetic training at Guy’s Hospital in London

Head of Sales & Marketing;
Board Member of numerous Biotechnology companies in Hong Kong and China;
Over 20 years of project management and sales marketing;
BSLA; EMIL; MBA

Over two decades of drug discovery and development expertise in pharma and biotech companies including Amgen, ImClone/Lilly, deCODE, Genea Biocells;
diverse modalities in mid/late stages of clinical developments to treat oncology, CNS, metabolic and neuromuscular disorders with specific emphasis on rare diseases;
over 170 peer-reviewed publications and over 60 granted patents and patent applications

Biotechnology Scientist;
Former Program Manager, Project Planning and Execution Group, Hong Kong Applied Science and Technology Research Institute Company Limited (ASTRI);
PhD, The Hong Kong Baptist University

Biochemistry Scientist;
Scientific Officer, The Chinese University of Hong Kong;
PhD, GradD, M.Phil., The Chinese University of Hong Kong

Laboratory Medical Science degree at the University of British Columbia in Canada; MPhil and PhD at the University of Hong Kong. The fellow of the Institute of Biomedical Sciences (FIBMS) in Britain. Worked at the University of Hong Kong for many years, and mainly engaged in cancer research and laboratory managementbefore joining Pangenia. The research results were published in various prestigious journals, such as Cancer Cell, Hepatology, Cancer, Gut and etc.

Medical oncologist;
Distinguished Professor and Chair, Department of Biochemistry and Molecular Medicine, UC Davis Health School of Medicine;
Sue Jane Leung Presidential Chair in Cancer Research & Harold Albin Johnson Endowed Chair in Biomedical Research, UC Davis NCI-Designated Comprehensive Cancer Center;
PhD in Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin;
MD, Stanford University School of Medicine

Pharmacologist;
Research Scientist, Stanford University;
Honorary Associate Professor, the University of Hong Kong;
President & Founder of Apollonian Biosystems Ltd./ Inc., Hong Kong and USA; Patent Holder;
PhD, & M.S., Yale University;
M.S., Columbia University

Tsao Yen-Chow Endowed Professor & Head, Department of Paediatrics & Adolescent Medicine, the University of Hong Kong;
Chief of Service, Department of Paediatrics & Adolescent Medicine, Hong Kong Children's Hospital, HKU-Shenzhen Hospital & Gleneagles Hospital;
Deputy Director, Stem Cells & Regenerative Medicine Consortium;
Chief Commission Service Coordinator (Paediatric Oncology), Hong Kong Children's Hospital. DMD & MD, the University of the East

Former National Sales & Marketing Director, Bio-Rad Laboratories Canada;
Former Asia-Pacific Chairman & President, PerkinElmer;
Member of the Advisory Council on Food and Environment Hygiene of the HKSAR Government;
Tenth Council member, the Chinese People’s Political Consultative Conference in Jilin province;
Honorary Fellow, the Hong Kong University of Science and Technology

Co-Founder & Co-CEO of MaLogic;
Former Group Chairman, Ogilvy in Hong Kong and Southern China;
Former Council Member of The HK Trade Development Council & The HK Academy for Performing Arts;
Member of the Advisory Committee on Arts Development;
Vetting Committee Member of the SME Development Fund & BUD Fund;
Former Advisory Committee Member for the ICAC, HK Museum, CEDB and the Education Bureau. Vice-Chairman of Plan International (HK);
University Fellowship, the Hong Kong Polytechnic University